EUVIMEDEUVIMED entdecken
Crossref

Trends in malignant mesothelioma incidence in Spain, 1999–2023: a joinpoint and age–period–cohort analysis

Lucia Cayuela, Anna Michela Gaeta, Julián Librero, Victoria Achaval Rodríguez, Aurelio Cayuela

Clinical and Translational Oncology · 22.06.2026

DOI: 10.1007/s12094-026-04478-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, online erschienen am 22.06.2026. Verfasst von Lucia Cayuela und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hospital Universitario Severo Ochoa, Leganés, Spain. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Malignant mesothelioma (MM) in Spain reflects historical asbestos consumption that peaked in the 1970s. Despite a 2002 ban, the absence of a national registry complicates burden estimation. We aimed to characterise incidence trends and generational risk patterns over 25 years. METHODS: This ecological study analysed Global Burden of Disease 2023 incidence data for Spain (1999-2023). Age-standardised incidence rates (ASIR) were calculated using the 2013 European Standard Population. Temporal trends were assessed via joinpoint regression. Age-period-cohort (A-P-C) modelling disentangled the independent effects of age, period, and birth cohort by sex. RESULTS: In men, ASIRs increased from 1·55 to 1·94 per 100,000 (1999-2012), followed by a significant decline after 2016 (annual percentage change [APC] - 2·3%, 95% CI - 3·9- - 1·3; p < 0·001). In women, rates remained low and stable (0.45-0.50 per 100,000), with a modest increase over time (average annual percentage change 0.6%, p < 0.001). A-P-C modelling in men revealed a significant negative net drift (- 1·45% per year, p < 0·001) and strong birth cohort effects peaking in the 1944 cohort, with marked risk reduction in those born after 1964 (relative risk < 0·70). Women showed no significant cohort or period effects and minimal temporal variation. CONCLUSIONS: Spain shows evidence of a meaningful epidemiological transition in its mesothelioma epidemic. The significant decline in male incidence since 2016 is consistent with the 2002 asbestos ban and the progressive ageing-out of heavily exposed cohorts.

Schlagwörter

Stichwörter der Autor:innen

Age–period–cohort analysisAsbestos exposureEpidemiologyIncidence trendsMalignant mesotheliomaOccupational cancerSpain

Autor:innen und Institutionen

  • Department of Internal Medicine, Hospital Universitario Severo Ochoa, Leganés, Spain.
  • Pulmonology Department, Hospital Universitario Severo Ochoa, Leganés, Spain. amgaeta84@gmail.com.
  • Navarrabiomed-HUN-UPNA, Red de Investigación en Cronicidad, Atención Primaria y Prevención y Promoción de La Saluds (RICAPPS), Pamplona, Spain.
  • Independent Researcher, Seville, Spain.

Zitieren

APA

Cayuela, L., Gaeta, A. M., Librero, J., Achaval Rodríguez, V., & Cayuela, A. (2026). Trends in malignant mesothelioma incidence in Spain, 1999–2023: a joinpoint and age–period–cohort analysis. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04478-3

Vancouver

Cayuela L, Gaeta AM, Librero J, Achaval Rodríguez V, Cayuela A. Trends in malignant mesothelioma incidence in Spain, 1999–2023: a joinpoint and age–period–cohort analysis. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04478-3

BibTeX
@article{Cayuela2026,
  author = {Cayuela, Lucia and Gaeta, Anna Michela and Librero, Julián and Achaval Rodríguez, Victoria and Cayuela, Aurelio},
  title = {Trends in malignant mesothelioma incidence in Spain, 1999–2023: a joinpoint and age–period–cohort analysis},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04478-3}
}
Kostenlos starten →